Products Listing CBD as Inactive Ingredient Cited for Unapproved Drug and Misbranding Violations The U.S. Food and Drug Administration has issued warning letters to two companies for selling products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). Specifically, the warning letters address the illegal marketing … Continue reading FDA Warns Companies Illegally Selling Over-the-Counter CBD Products for Pain Relief